(MMI), a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients with complex ...

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on July 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an ...

The closing of the offering is expected to occur on or about July 10, 2025, subject to the satisfaction of customary closing conditions. The gross proceeds from the offering are expected to be ...

Annette Slyman, Chief Operating Officer, Life Backup Plan by Galacxia, Inc ...

Mr. Mahatme brings decades of experience in strategic finance, capital formation, and operational leadership to support company’s transformation and growth in autoimmune disease CAMBRIDGE, Mass., July ...

“This partnership is all about ensuring a seamless and positive future for Strongline customers,” said Shan Sinha, CEO of Canopy. “We are honored to bring our dedicated focus on healthcare safety to ...

The Canadian Red Cross, in collaboration with Walmart Canada, is pleased to announce its annual giving campaign in support of emergency response. For the month of July, Walmart customers across Canada ...

Company to Showcase Progress on Radical Catheter Portfolio and Best-in-Class Ribbon Technology Platform at Society of Neurointerventional Surgery Annual Meeting. LOS GATOS, calif.

SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and ...

Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing and screening solutions, today announced that ...

ARLINGTON, Va., July 10, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its second-quarter and six-month periods ...

Lisaftoclax is a proprietary, novel orally administered small-molecule Bcl-2 selective inhibitor developed by Ascentage Pharma to treat patients with malignancies by selectively blocking the ...